- Clinical Trials
- April 2024
- 40 Pages
Global
From €1208EUR$1,250USD£1,039GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1208EUR$1,250USD£1,039GBP
- Clinical Trials
- April 2024
- 40 Pages
Global
From €1208EUR$1,250USD£1,039GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1208EUR$1,250USD£1,039GBP
- Drug Pipelines
- April 2024
- 80 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Report
- February 2024
- 150 Pages
Global
From €4109EUR$4,250USD£3,531GBP
- Report
- February 2024
- 30 Pages
Global
From €3142EUR$3,250USD£2,700GBP
- Report
- January 2024
- 189 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Clinical Trials
- January 2024
- 100 Pages
Global
From €1933EUR$2,000USD£1,662GBP
- Clinical Trials
- January 2024
- 60 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Drug Pipelines
- January 2024
- 60 Pages
Global
From €1450EUR$1,500USD£1,246GBP
- Report
- November 2023
- 30 Pages
Global
From €2658EUR$2,750USD£2,285GBP
- Report
- November 2023
- 30 Pages
Global
From €2658EUR$2,750USD£2,285GBP
- Report
- November 2023
- 30 Pages
Global
From €2658EUR$2,750USD£2,285GBP
- Report
- August 2023
- 201 Pages
Global
From €7250EUR$7,500USD£6,232GBP
- Report
- April 2024
- 185 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- April 2024
- 187 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 190 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 182 Pages
Global
From €4737EUR$4,900USD£4,071GBP
- Report
- October 2023
- 175 Pages
Global
From €4737EUR$4,900USD£4,071GBP
The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more